| Real-world evidence research based on big data Motivation-challenges-success factors |
7 |
| Data literacy in medicine. What competences does a physician need? |
4 |
| Epidemiology of head and neck cancer in Germany |
3 |
| Epidemiology of hepatocellular carcinoma in Germany |
3 |
| Complementary medical treatment approaches for oral mucositis and xerostomia |
3 |
| Complementary medical treatment approaches for patients with loss of smell and taste |
3 |
| Epidemiology of ovarian cancer in Germany |
3 |
| Positive and negative changes in life after cancer diagnosis. A prospective mixed-methods study |
2 |
| Fact sheet: Epidemiology of malignant melanoma in Germany |
1 |
| Special aspects of palliative care for patients with head and neck cancer |
1 |
| Long-term quality of life in head and neck cancer patients. A systematic review. German version |
1 |
| Music therapy in psycho-oncology |
1 |
| From geriatric assessment to geriatric intervention |
1 |
| Fact sheet: epidemiology of Hodgkin's lymphoma in Germany |
1 |
| Update: palliative radiotherapy of bone metastases. Recommendations of the German S3 guidelines on supportive therapy for cancer patients |
1 |
| Complementary medical treatment approaches for patients with loss of appetite and esophagitis |
1 |
| Impact of surgery ofmetastases in advanced pancreatic cancer |
1 |
| Current standards and perspectives in pancreatic cancer surgery |
1 |
| Comorbid mental disorders in bone and soft tissue sarcoma |
1 |
| Epidemiology of pancreatic cancer in Germany |
1 |
| Treatment options for sarcomas of the spine. A heterogenic disease picture which requires an individual and interdisciplinary treatment concept |
1 |
| Epidemiology of prostate cancer in Germany |
1 |
| Intermediate-risk profile in prostate cancer. Role of combined radiation and hormone therapy |
1 |
| Psycho-oncological healthcare needs of patients with non-Hodgkin's lymphoma |
1 |
| Epidemiology of vulvar and vaginal cancer in Germany |
1 |
| Epidemiology of renal cell carcinoma in Germany |
1 |
| Partnership and sexuality in cancerous diseases |
1 |
| Patient reported outcome measurement (PROM) of psychosocial distress and symptom burden in outpatients with cancer treatment in curative and palliative intent-a retrospective evaluation of a comprehensive cancer center |
1 |
| Epidemiology of selected endocrine tumors in Germany |
1 |
| Chronic myeloid leukemia |
1 |
| Hypercalcemia |
1 |
| Endometrial cancer. A review with current aspects |
1 |
| Immunotherapy for melanoma |
1 |
| The paradigm shift toward stereotactic radiotherapy in oligometastatic disease |
1 |
| The oncological patient in the field of tension between scientific standards and practical individualization in oncology A plea for an integrative oncology |
1 |
| Psycho-oncology Requirements for the next years |
1 |
| Operative treatment of early and advanced ovarian cancer |
1 |
| Why does a thyroid tumor have to be classified as a carcinoma if it does not biologically behave like cancer? Noninvasive follicular thyroid neoplasm with papillary-like nuclear features as a model |
1 |
| Potential and evidence for robot-assisted procedures in surgical oncology |
0 |
| Contribution of epidemiology to primary prevention of cancer |
0 |
| Psychosocial aspects of patients with bladder cancer |
0 |
| Immunostimulants from naturopathy. Use in myeloproliferative diseases? |
0 |
| Merkel cell carcinoma |
0 |
| Quality of life of survivors of non-small cell lung cancer. Overview of associated factors and requirements for aftercare |
0 |
| Hypnotherapeutic interventions for pain treatment |
0 |
| Surgical treatment of stage I and II non-small cell lung cancer |
0 |
| Medicinal treatment of metastatic or recurrent NSCLC without driver mutations |
0 |
| Perioperative chemotherapy of bladder cancer. Neoadjuvant, inductive and adjuvant strategies |
0 |
| Radiochemotherapy of bladder cancer. An alternative to radical cystectomy |
0 |
| Diagnostics and surgical treatment of muscle-invasive bladder cancer |
0 |
